AU2002361450A1 - Novel pharmaceutical - Google Patents
Novel pharmaceuticalInfo
- Publication number
- AU2002361450A1 AU2002361450A1 AU2002361450A AU2002361450A AU2002361450A1 AU 2002361450 A1 AU2002361450 A1 AU 2002361450A1 AU 2002361450 A AU2002361450 A AU 2002361450A AU 2002361450 A AU2002361450 A AU 2002361450A AU 2002361450 A1 AU2002361450 A1 AU 2002361450A1
- Authority
- AU
- Australia
- Prior art keywords
- novel pharmaceutical
- pharmaceutical
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0130510.1 | 2001-12-20 | ||
| GBGB0130510.1A GB0130510D0 (en) | 2001-12-20 | 2001-12-20 | Novel pharmaceutical |
| PCT/GB2002/005815 WO2003053963A1 (en) | 2001-12-20 | 2002-12-19 | Novel pharmaceutical |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002361450A1 true AU2002361450A1 (en) | 2003-07-09 |
Family
ID=9928053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002361450A Abandoned AU2002361450A1 (en) | 2001-12-20 | 2002-12-19 | Novel pharmaceutical |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2002361450A1 (en) |
| GB (1) | GB0130510D0 (en) |
| WO (1) | WO2003053963A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR047541A1 (en) * | 2004-02-13 | 2006-01-25 | Sandoz Ag | PHOSPHATE OF 5 - [[4- [2-METHYL-2-PYRIDINYL-AMINO-ETOXI] PHENYL] METHYL] -2,4 THYZOLIDINADION (ROSIGLITAZONE) AND ITS POLYMORPHIC FORMS |
| DE102005034406A1 (en) * | 2005-07-22 | 2007-02-01 | Ratiopharm Gmbh | New salts of rosiglitazone |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10199003I1 (en) * | 1987-09-04 | 2003-06-12 | Beecham Group Plc | Substituted thiazolidine ion derivatives |
| EP1078629A3 (en) * | 1989-09-07 | 2001-05-23 | Glaxo Group Limited | Use of Salmeterol and salts for the treatment of inflammation and allergy |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
-
2001
- 2001-12-20 GB GBGB0130510.1A patent/GB0130510D0/en not_active Ceased
-
2002
- 2002-12-19 WO PCT/GB2002/005815 patent/WO2003053963A1/en not_active Ceased
- 2002-12-19 AU AU2002361450A patent/AU2002361450A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| GB0130510D0 (en) | 2002-02-06 |
| WO2003053963A1 (en) | 2003-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002365120A1 (en) | Medicaments | |
| AU2002302147A1 (en) | Pharmaceutical composition | |
| AU2002253039A1 (en) | Tramadol-based medicament | |
| AU2002257582A1 (en) | Pharmaceutical formulation | |
| AU2002258221A1 (en) | Medicinal composition | |
| AU2002359320A1 (en) | Novel anit-infectives | |
| AU2002333276A1 (en) | Drugs for vasculopaties | |
| GB0129872D0 (en) | Novel pharmaceutical | |
| AU2002354460A1 (en) | Medicinal composition | |
| AUPR529701A0 (en) | Pharmaceutical composition | |
| AU2002361450A1 (en) | Novel pharmaceutical | |
| AU2002342940A1 (en) | New pharmaceutical compounds | |
| AU2001100406A4 (en) | DriverSMS | |
| GB0130511D0 (en) | Novel pharmaceutical | |
| GB0130509D0 (en) | Novel pharmaceutical | |
| GB0129876D0 (en) | Novel pharmaceutical | |
| GB0129871D0 (en) | Novel pharmaceutical | |
| HK1061812A (en) | Pharmaceutical combinations | |
| AU2002100921A4 (en) | Pharmaceutical composition | |
| AU2002251537A1 (en) | Medicines | |
| AUPR430501A0 (en) | Pharmaceutical composition | |
| AU2002344087A1 (en) | Pharmaceutical composition | |
| AU2002345799A1 (en) | Pharmaceutical composition | |
| AUPR668401A0 (en) | Pharmaceutical composition | |
| AU2002334736A1 (en) | Fondant-based pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |